This week, our Programmatic Channel Director had the opportunity to represent Butler/Till at the 2024 Pharma CX Marketing Summit, joining the panel “The Future of Programmatic in Pharma: Innovation Meets Precision”, hosted by our strategic partner, PulsePoint. Our conversation highlighted the rapid evolution of how we leverage data, AI, and CDPs (Customer Data Platforms) to create more personalized and effective marketing strategies in healthcare.
We shared a few key areas where we’re innovating at Butler/Till:
- We highlighted our Conditions Marketplace, an exclusive targeting offering that is helping us build curated programmatic supply tailored for healthcare.
- We spoke about our Butler/Till Quality Index (BTQI) which combats MFA (Made-for-Advertising) content to ensure our campaigns run in premium, trusted environments.
- Additionally, we shared how we’re using our spending power to negotiate favorable rates, turning those savings directly into innovation initiatives for our clients.
Across the conference, three themes resonated with our attendees:
- First, AI is shaping more personalized and empathetic patient experiences, moving beyond automation to truly enhance the HCP and patient journeys.
- Second, CDPs are gaining traction as the solution to manage and activate vast data resources, bridging the gap between data overload and actionable insights.
- Finally, there was a call to become change agents within our own teams—by embracing tools like AI and CDPs, we can disrupt from within, driving forward a new era of precision and patient-centered care.
It was inspiring to discuss these advancements alongside leaders who are equally committed to pushing boundaries in healthcare marketing. Here’s to building a smarter, more impactful future in pharma!
